Clinical validation of the CD32b biomarker on the European market

Lynn Goldin

Autoimmune Diseases and Risk for Lymphoma and Other Cancers

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Keisuke Ito

Epigenetic regulation by microRNA of MDS pathogenesis

Leukaemia

Hematology and hematologic malignancies

Linda J Burns

Training and Mentorship of Hematologic Oncologists

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Ann Mullally

Functional and Molecular Dissection of Myeloproliferative Neoplasm Stem Cells

Leukaemia

John D Schuetz

Metabolic pathways in leukemia

Leukaemia

Anthony G Letai

Probing mitochondria and personalizing leukemia therapy with BH3 profiling

Leukaemia

Robert Kreitman

Development of Recombinant Toxins to Treat Hematologic Malignancies

Leukaemia

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Tak Mak

CRC Tier 1 - Determining why mutations of the metabolic enzyme isocitrate dehydrogenase cause leukemias and brain cancers

Leukaemia Brain, nervous system

Nathaniel Rothman

Studies in the Janus Cohort

Trachea, bronchus and lung Thyroid Testis Prostate Pancreas Ovary Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Lip, oral cavity Leukaemia

Pathology